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Abstract 
Intramedullary Spinal Cord Ependymomas (ISCE) are 
uncommon pathologies that need to be aggressively 
managed before clinical deterioration sets in. Novel 
application of different therapeutic strategies is being 
assessed for improving long-term outcomes in patients 
presenting with these rare neoplasms. In this review, we 
have discussed the existing literature on ISCEs, and the 
role of surgery in determining outcomes in terms of 
neurological status, progression-free survival (PFS) and 
overall survival (OS).  
Keywords: Ependymoma, Spinal cord tumour, 
Intramedullary tumour. 
Introduction 
Intramedullary spinal cord tumours account for 4-10% of 
all primary central nervous system (CNS) neoplasms.1,2 
Approximately 60% of all intramedullary neoplasms are 
spinal ependymomas, more common in adults than in 
children.2,3 The WHO categorizes spinal ependymomas 
into 3 histological subtypes: grade I myxopapillary 
ependymoma, usually extramedullary; grade II or classic 
ependymoma (CE), which includes the cellular, clear cell, 
tanycytic, and papillary subtypes; and grade III anaplastic 
ependymoma.3-6 Despite demonstrating a relatively 
benign course and a usually well-defined dissection plane 
in comparison to other intramedullary entities, their 
tendency towards recurrence, malignant transformation, 
and metastasising along the neuroaxis frequently results 
in significant morbidity and mortality.1,7 Herein, we have 
reviewed the literature pertaining to the survival 
outcomes in patients undergoing treatment for 
intramedullary spinal cord ependymomas.  
Review of Literature 
Ohata et al., published their series of 18 patients who 
underwent surgery for intramedullary spinal cord 
ependymoma ranging from grade I to III. They achieved 
gross total resection (GTR) in 17 patients, while 1 patient, 
with a grade II ependymoma, received sub-total resection 
(STR) followed by adjuvant radiotherapy (RT) of 20 Gy. 
While there was no surgical mortality, there were either 
worsening deficits or new onset deficits in 10 cases: 
transient in 7 cases. Follow-up ranged from 10 months to 
249 months, with no evidence of clinical or radiological 
recurrence. The final neurological outcome was improved 
in 1 case, remained unchanged in 15 cases, and worse in 
2 cases.8 
Oh et al., reviewed 68 studies in 2012, reporting that 268 
(77%) out of the 348 total patients with intramedullary 
ependymomas received GTR, while the remaining 80 
(23%) received STR. Out of the latter, 47 patients also 
received RT. The authors demonstrated significantly 
lower GTR rates with lower spinal cord ependymomas 
and anaplastic pathologies (p = 0.001). A significantly 
longer progression free survival (PFS), with an 
improvement of 20.2% in the five-year PFS rate, was 
reported in patients receiving RT with STR, compared to 
those receiving STR alone. The median PFS time was 48 
months in the STR group, which was doubled to 96 
months with RT. Although more recurrences were 
observed in the group with a higher radiation dose (>50 
Gy), the results were not statistically significant. However, 
improved OS was only associated with GTR and benign 
ependymomas, with the five-year overall survival (OS) for 
GTR, STR + RT, and STR groups being 98.8%, 79.3%, and 
73.7%, respectively.9 
In their 20 years’ experience of treating 24 pediatric 
patients, Safaee et al., reported similar outcomes between 
grade I and grade II lesions with respect to PFS; and extent 
of resection was suggested to be the most important 
prognostic factor in terms of survival outcomes. A 
significantly better PFS was reported in patients with GTR. 
Extent of resection was more variable in grade II lesions. 
The authors also reported difficulty in achieving GTR in 
the upper spinal cord, making tumour location another 
significant prognostic factor. There was no immediate or 
long-term post-operative mortality.10 
Klekamp et al., described their experience with 100 
patients with intramedullary ependymomas. In their 
series, thoracic ependymomas demonstrated a relatively 
worse preoperative clinical course as compared to 
cervical tumours. They reported increased risk of 
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permanent morbidity with advanced age, thoracic 
ependymomas, long clinical history, presence of a tumour 
bleed, and surgery on a recurrent lesion. Altogether 
86.3% patients underwent GTR, with a low preoperative 
McCormick functional classification grade8 and first 
surgery was reported as a strong predictor for complete 
resection. 67.6% of the patients deteriorated 
neurologically in the early postoperative period, with the 
deficit being transient for 40.1% of the patients, and 
permanent for 27.5%. PFS rates correlated significantly 
with extent of resection, with the 20-year recurrence rate 
for GTR and STR being 4.2% and 18.5% respectively. 
Corresponding OS at 20 years was 92%, with seven deaths 
during follow-up. Out of these, 3 were unrelated, 2 were 
related to surgery and happened within six weeks post-
operatively,  one occurred within a year due to post-
operative paraplegia-related complications, and 1 was 
due to cranial tumours associated with NF-2.1 
Lin et al., retrospectively analyzed 64 paediatric patients 
with grade II intramedullary ependymomas. 57% of the 
subjects underwent GTR. 55 patients were alive at the 
median follow-up of 9.2 years, while 9 died at a median of 
15 months post-operatively. OS at 5 and 10 years was 86% 
and 83%, respectively. In a multivariate regression model 
analyzing sex, age at diagnosis, year of diagnosis, 
radiotherapy, and extent of resection, female sex was 
found to be an independent predictor of decreased 
mortality. Tumour progression and recurrence were not 
reported in the study.4 
Behmanesh et al., published their series of 28 consecutive 
patients with intramedullary spinal ependymomas, in 
which 25 were WHO grade II, and the rest, grade III. GTR 
was achieved in 93% of patients. Four patients had 
tumour recurrence, for which they underwent second and 
third surgeries. While 3 patients experienced minor post-
operative complications, there was no mortality within 30 
post-operative days. PFS at 5 and 10 was 91% and 85%, 
respectively, although OS was not reported. An 
interesting observation was the correlation of permanent 
unfavourable outcome in 5 out of the 15 (53%) patients, 
whose radiology showed spinal cord atrophy at the site of 
resection, at the last follow up.2 
Svoboda et al., reported 37 patients with intramedullary 
ependymomas. Most patients presented with the lesion 
in the cervical region, with either a syrinx formation (49%) 
or a cyst (32%), seen radiologically. GTR was achieved in 
89% of the patients, while 3 patients underwent STR. At a 
median follow up of 114 months, PFS was 87%, 82%, and 
82% at 5, 10, and 15 years, respectively. OS was 97%, 88%, 
and 63% at 5, 10, and 15 years, respectively. The 
recurrence rate strongly correlated with the extent of 
resection, making GTR the most important factor for PFS. 
OS however was more significantly associated with 
preoperative clinical status, being significantly better in 
patients who had McCormick grades 1 and 2 pre-
operatively.5 
Wostrack et al., reported their multicenter retrospective 
experience of 158 adult patients and concluded that GTR 
was the most important survival predictor, even with 
permanent deficits. GTR was obtained in 80% of the 
patients, with 37% showing worsening of neurological 
status at discharge. Follow up revealed recovery in 
majority, whereas 76% showed at least pre-operative 
status. Transient deficits significantly correlated with 
cervically located ependymomas and old age. Permanent 
deficits, observed in 2% of the patients, were only 
Figure: a) MRI cervical T1WI spine mid-sagittal sections showing C5-T1 iso-intense lesion; b) T2WI (fat-suppressed) of the same patient showing hyper-intense lesion associated with 
syrinx; I) T1WI with contrast showing heterogeneous contrast enhancement.
significantly seen in the older patients. Tumour 
progression was observed in 15 cases, with the 5-year PFS 
being 80%. The PFS of 15 patients who underwent RT 
after first surgery was significantly shorter than those who 
underwent surgery alone (p < 0.001). However, no 
statistically relevant effects of RT, received by 9 patients in 
the STR sub-group, were noticed. GTR (p = 0.037), WHO 
grade II (p = 0.009), and low Ki-67 index (p = 0.005) were 
significant prognostic variables for PFS. The authors did 
not report OS in these patients.7 
Conclusion 
Intramedullary spinal cord ependymomas are rare and 
challenging pathologies. While adjuvant radiotherapy 
with sub-total resection does prolong progression free 
survival, gross total resection remains the cornerstone for 
better outcomes. Overall survival, however, mostly 
depends upon the pre-operative status and tumour 
recurrence. Thus, early and active surgical treatment 
aiming at complete tumour removal optimizes long terms 
survival outcomes for these patients. 
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